Company / Debt per Share
TG Therapeutics, Inc. Debt per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$1.58
FY2025
5-year range
$0.48 / $1.61
FY2021-FY2025
Trend
-2.3%
vs FY2024
Sector context
#47 of 82
Health Care
What the data says
At $1.58, TG Therapeutics, Inc.'s debt per share ranks #36 of 82 in the Health Care sector. Debt per Share has fluctuated over the past 8 years, ranging from $0.00 in FY2018 to $1.61 in FY2024.
Based on SEC 10-K filings.
1.58 in FY2025 with a 5-year CAGR of +42.0%.
Increased from $0.69 to $1.58 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- +47.0%
- 5-Year CAGR
- +42.0%
- 10-Year CAGR
- -
Sector benchmark
#36 of 82 in Health CareTop 43% of 82This company $1.58 Sector average $151.59
▼
-99.0% below sector average
Key checks
Key Insights
- In FY2025, debt per share decreased 2.3% year-over-year.
- Ranks #47 out of 82 companies in the Health Care sector.
- Peak debt per share was recorded in FY2024.
- Lowest debt per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.58 | -2.3% |
| FY2024 | $1.61 | +135.3% |
| FY2023 | $0.69 | +38.1% |
| FY2022 | $0.50 | +3.0% |
| FY2021 | $0.48 | +76.4% |
| FY2020 | $0.27 | -20.9% |
| FY2019 | $0.35 | - |
| FY2018 | $0.00 | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026